Sign inJoin waitlistJoin the waitlist

Stephen DePasquale

Associate Program Director, MIGS Fellowship · University of Tennessee College of Medicine

Credentials: · · · · · ·

History

MIGS Fellowship · University of Tennessee College of Medicine
Present
Department of OB/GYN · University of Tennessee College of Medicine
Present
Department of Obstetrics & Gynecology · University of Tennessee College of Medicine
Present

2001–2004
Obstetrics and Gynecology
Pennsylvania Hospital
1997–2001
University of Medicine and Dentistry of New Jersey
1989–1993

Research

PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant…
Journal of Clinical Oncology · 2013 · 168 citations
Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulva
Gynecologic Oncology · 2003 · 79 citations
Adenoid cystic carcinoma of Bartholin's gland: a review of the literature and report of a patient
Case report · Gynecologic Oncology · 1996 · First of 5 authors · 37 citations

RE
Rayan Elkattah
7 papers · 4 as a resident
SM
Shanti Mohling
5 papers
Todd Boren
4 papers · 2 as a fellow
MS
Margaret Steinhoff
3 papers
Talla Widelock
3 papers · 3 as a resident
WG
Walter Gajewski
3 papers
Carlos Torres
2 papers · 1 as a fellow
CA
Charles Adair
2 papers
Christy Pearce
2 papers · 2 as a resident
Lynlee Wolfe
2 papers · 2 as a resident
Mark Woodland
2 papers
RF
Robert Furr
2 papers

Clinical trials

A Pilot Study to Evaluate Ultrasonic Surgical Aspiration as a Treatment Modality for Cervical Dysplasia
Principal investigator · Completed
University of Tennessee
2004–2006
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
Site PI · Recruiting · Phase 3
Imunon
2025–2032
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Site PI · Recruiting · Phase 3
Genelux Corporation
2022–2027
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Site PI · Recruiting
GOG Foundation
2022–2030